WILMINGTON, MASSACHUSETTS--(Marketwire - October 01, 2007) - DUSA Pharmaceuticals, Inc.® (NASDAQ GM: DUSA), is pleased to announce that the first shipment of Levulan® Kerastick® has been released to Argentina and Mexico where it will be officially launched through its marketing partner for Latin America, Stiefel Laboratories, Inc. Having previously received regulatory approval, initial marketing and training activities have begun in these countries and the product launch is eagerly anticipated. In Latin America, Levulan has regulatory approval in Argentina, Mexico, Chile (where launch is imminent) and Brazil (where launch is pending receipt of acceptable pricing approval) with approvals and subsequent product launches in additional markets scheduled to follow shortly.
